1. Scrip
  2. >>Focus On Asia

Positive Results Move Anemia Contender Enarodustat Towards First Filing

 
• By Ian Haydock

Japanese firms unveil pivotal top-line results that pave way for first filing of novel anemia therapy within new class of agents, but competition is high and timings remain unclear.

Human kidney on scientific background. 3d illustration
JT/Torii's Enarodustat Moves Towards First Filing • Source: Shutterstock

Japanese firm Torii Pharmaceutical Co. Ltd. and parent Japan Tobacco Inc. (JT) are planning a marketing authorization filing in Japan for their oral inhibitor of hypoxia inducible factor-prolyl hydroxylase (HIF-PH), following positive results in comparative Phase III trials.

The new top-line results came from two pivotal studies conducted in Japan with enarodustat (JTZ-951) in either anemic patients with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Focus On Asia

Sino Biopharm Scoops LaNova In Chinese Pharma’s Biggest Biotech Buyout So Far

 
• By Dexter Jie Yan

Sino Biopharm will pay almost $1bn to acquire what target LaNova’s CEO described as an “exploding” pipeline, which includes six clinical-stage candidates in the oncology area.

China Sentences Astellas Employee To 3.5 Years In Prison On Spy Charges

 
• By Lisa Takagi

An employee of Astellas faces three and a half years in prison after sentencing by a court in China on espionage charges.

Sun’s Alopecia Treatment Debuts In US - Can It Make Up For Lost Time?

 
• By Anju Ghangurde

Sun’s Leqselvi goes up against Lilly's Olumiant and Pfizer's Litfulo, which currently has the broadest label, in the US alopecia market. Can it shake things up early, amid growing activity in the space with several new mechanisms of action being investigated?